Ventyx Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,076 | $0 |
Gross Profit | -316 | -408 | 673 | -265 |
EBITDA | -35,396 | -41,360 | -47,743 | -57,951 |
EBIT | -35,712 | -41,768 | -48,146 | -58,216 |
Net Income | -31,950 | -38,572 | -46,753 | -54,027 |
Net Change In Cash | 0 | 0 | 1,076 | 0 |
Free Cash Flow | -24,598 | -47,800 | -51,866 | -34,712 |
Cash | 40,925 | 141,898 | 51,579 | 56,610 |
Basic Shares | 70,554 | 61,829 | 59,076 | 58,880 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -941 | -470 | -30 | |
EBITDA | -207,836 | -108,426 | -72,596 | -7,051 |
EBIT | -207,994 | -108,896 | -72,626 | -14,101 |
Net Income | -192,962 | -107,956 | -78,366 | -28,532 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -5,930 | 70,547 | ||
Free Cash Flow | -167,036 | -99,046 | -38,912 | -6,195 |
Cash | 51,579 | 64,819 | 70,791 | 244 |
Basic Shares | 58,542 | 52,471 | 50,408 | 50,296 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.45 |
2024-03-31 | -$0.62 |
2023-12-31 | -$0.79 |
2023-09-30 | -$0.92 |
